41 results match your criteria: "From Tufts University[Affiliation]"
Nailing the Nail Biopsy: Surgical Instruments and Their Function in Nail Biopsy Procedures.
Cutis
October 2024
Rachel C. Hill is from Weill Cornell Medical College, New York, New York. Apostolos Katsiaunis is from Tufts University School of Medicine, Boston, Massachusetts. Dr. Lipner is from the Department of Dermatology, Weill Cornell Medicine, New York.
Nail surgeries, including nail biopsies (NBs), are performed relatively infrequently-perhaps due to dermatologists' unfamiliarity with nail unit anatomy and lack of formal NB training during residency. To address this educational gap, we sought to create a guide that details the surgical instruments used for the nail matrix tangential excision (shave) biopsy technique-the most common technique used in our nail specialty clinic.
View Article and Find Full Text PDFA Diagnostic Sequence.
N Engl J Med
November 2024
From Tufts University School of Medicine, Departments of Medicine and Pediatrics (C.L.), and Boston Children's Hospital (J.R.B.) - both in Boston.
Possibly Misleading Pharmaceutical Advertising On TV: A 2023 Ad for Ingrezza.
J Clin Psychopharmacol
April 2024
From Tufts University School of Medicine, Center for the Study of Drug Development, Boston, Massachusetts.
Nutrition in Medicine - A New Review Article Series.
N Engl J Med
April 2024
From Tufts University School of Medicine, Boston, and the Department of Hospital and Pediatrics, Newton-Wellesley Hospital, Newton, MA (C.D.L.).
The Placenta and Psychiatry: Reinforcing Information.
J Clin Psychopharmacol
December 2023
From Tufts University School of Medicine (TUSM), The Tufts Center for the Study of Drug Development (TUSM), Boston, Massachusetts.
Transient Skin Rippling in an Infant.
Cutis
September 2023
Department of Dermatology, Boston Children's Hospital, Massachusetts, and the Department of Dermatology, Massachusetts General Hospital, Boston. Mia A. Mologousis also is from Tufts University School of Medicine, Boston. Dr. Hawryluk also is from Harvard Medical School, Boston.
Shifting Tides Offer New Hope For Obesity.
N Engl J Med
July 2022
From Tufts University School of Medicine, Boston, and the Center for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough (C.J.R.).
Clinical Quality Measures: A Challenge for-and to-Family Physicians.
J Am Board Fam Med
April 2022
From Tufts University School of Medicine (AD, WA); Harvard Medical School (AD); University of Massachusetts Medical School (RA, AME); University of California Davis School of Medicine (AA); and Computable Publishing, Ipswich, MA (BSA).
Introduction: Improving design, selection and implementation of appropriate clinical quality measures can reduce harms and costs of health care and improve the quality and experience of care delivery. These measures have not been evaluated for appropriateness for use in performance measurement in a systematic, reproducible, and widely accepted manner.
Methods: We defined 10 criteria for evaluation of measure appropriateness in 4 domains: Patient-centeredness of outcomes, specification of population measured and measure detail, reliable evidence that benefits likely outweigh harms, and independence from significant confounders.
Health Literacy, Health Confidence, and Simulation: A Novel Approach to Patient Education to Reduce Readmissions.
Prof Case Manag
October 2021
Colleen M. Morley, DNP, RN, CCM, CMAC, CMCN, ACM-RN, is the Director of Case Management Services for West Suburban Medical Center in Oak Park, IL, for Pipeline Health. She has more than 20 years of nursing experience. She is currently serving as the President for CMSA Chicago, Director on CMSA National Board, and Secretary for ANA-Illinois.
STEP 1 for Effective Weight Control - Another First Step?
N Engl J Med
March 2021
From Tufts University School of Medicine, Boston, and the Center for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough (C.J.R.).
Approach to the Diagnosis of Hepatocutaneous Syndrome in Dogs: A Retrospective Study and Literature Review.
J Am Anim Hosp Assoc
January 2021
From Tufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts (K.B.D., C.R.L.W., D.P.); and Universitat Autonoma de Barcelona, Barcelona, Spain (L.F.).
Superficial necrolytic dermatitis (SND) is a rare and often fatal disease in dogs that has been associated with pancreatic neuroendocrine neoplasia (SND/EN) and hepatocutaneous syndrome (SND/HCS). Although various combinations of diagnostics have been used to differentiate these two causes of SND, there are currently no data on which combination would enable the most timely and noninvasive way to diagnose HCS. Medical records were reviewed retrospectively (2004-2018) for dogs with SND/HCS (n = 24) and SND/EN (n = 1).
View Article and Find Full Text PDFFinerenone - Halting Relative Hyperaldosteronism in Chronic Kidney Disease.
N Engl J Med
December 2020
From Tufts University School of Medicine, Boston, and the Center for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough (C.J.R.).
Bariatric Surgery and Restoration of Insulin Sensitivity - It's Weight Loss.
N Engl J Med
August 2020
From Tufts University School of Medicine, Boston (C.J.R.); and the Center for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough (C.J.R.).
Diazepam in the Elderly: Looking Back, Ahead, and at the Evidence.
J Clin Psychopharmacol
January 2021
From Tufts University School of Medicine, Boston, MA.
A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment.
J Am Board Fam Med
April 2021
From Tufts University School of Medicine, Boston, MA (RS, AFS); Department of Psychiatry, Harvard Medical School, Boston, MA (ZS-O); Harvard Medical School, Boston, MA (MB); Malden Family Medicine Center, Cambridge Health Alliance, Malden, MA (LS, RS, AFS).
Background: Given that prescribing practices have contributed to the current opioid epidemic and that primary care clinicians are the largest prescribers of opioids, family physicians must consider the twin goals of safely prescribing opioids for patients with chronic pain while effectively identifying and treating those who have developed opioid use disorder (OUD). However, family physicians may feel constrained by a culture and systems in their offices that do not support achieving these twin goals.
Methods: In a family medicine clinic within a larger academic institution that cares for an underserved, multicultural patient population in the greater Boston area, we provide a case study that illustrates the twin goals of safe opioid prescribing and treating OUD.
In Addition to Pharmacotherapy and Psychotherapy for Psychosis, Is Anything Else Useful?
J Clin Psychopharmacol
October 2020
From Tufts University School of Medicine, Boston, MA.
Food Waste: Addressing our 160 Billion Pound Public Health Challenge with Policy and Business Interventions.
J Law Med Ethics
June 2019
Mathew Swinburne, J.D., is the Associate Director for the Network for Public Health Law's Eastern Region. He received a J.D. from the University of Maryland Francis King Carey School of Law in Baltimore, MD and a B.S. from Tufts University in Medford, MA. Katie Sandson, J.D., is a Clinical Fellow in the Food Law and Policy Clinic at Harvard Law School. She received a J.D. from Harvard Law School in Cambridge, MA and a B.A. in English Literature from Washington University in St. Louis, MO.
The United States wastes approximately 40% of its food supply. This article will examine the implications of this waste for food insecurity and climate change. It will also explore how the law and social entrepreneurship can be used to confront this public health challenge.
View Article and Find Full Text PDFMultiple subcutaneous dermoid cysts.
Cutis
May 2019
Division of Dermatology, Washington University, St. Louis, Missouri, USA.
Lorcaserin - Elixir or Liability?
N Engl J Med
September 2018
From Tufts University School of Medicine, Boston, and Maine Medical Center Research Institute, Scarborough (C.J.R.).
Economic and Clinical Outcomes Resulting From the Stage 4 Chronic Kidney Disease Case Management Quality Improvement Initiative.
Prof Case Manag
September 2018
Beverly Everett, MD, FACP, holds an MD degree from Tufts University School of Medicine, completed her Internal Medicine residency and Nephrology Fellowship at the University of North Carolina at Chapel Hill, practiced medicine for 15 years before joining Cigna, and after 18 years retired in 2015. Liana D. Castel, PhD, is Editor-in-Chief of Patient Related Outcome Measures (Dove Medical Press, Ltd), Adjunct Professor at the University of Mount Olive Tillman School of Business, and medical writer at Cigna. She holds a PhD degree from the University of North Carolina at Chapel Hill. Her research interests include outcomes and statistics. Matthew McGinnis, BS, has been with Cigna more than 13 years and leads the analytics team supporting Cigna's pharmacy benefits management business. He holds a US Patent for an End of Life Predictive Model, a Master of Science degree from Northwestern University, Illinois, and Certificate in Public Health from University of Florida. Amy Beresky, MS, holds a Master of Science in Statistics degree from University of Massachusetts Amherst. She has 8 years' experience in health care data mining, analytics, and predictive modeling, supporting Cigna's clinical programs, is fluent in Spanish, and has served on the Board of Directors and Environmental Committee in the residential community. Rudolph C. Cane Jr., MD, is Medical Director for Cigna Healthcare, Department of Clinical Performance and Quality. He holds board certification in Internal Medicine, completed Internal Medicine residency at Franklin Square Hospital Center, surgical internship at St. Agnes Medical Center, Baltimore, MD, and holds an MD degree from the University of Maryland School of Medicine. Tasha Cooper, RN, is a registered nurse who has been employed by Cigna for more than 20 years, holding various roles in the areas of Clinical Program Development, Case Management, Utilization Management, Disease Management, and Quality Accreditation and Compliance. Her career also includes more than 8 years of hospital and home health nursing experience. Rajesh K. Davda, MD, is the National Medical Director for network performance and quality improvement at Cigna Healthcare. Dr. Rajesh is board certified in internal medicine, nephrology and clinical informatics. Before joining Cigna in 2012, Raj was in private practice for 22 years in South Carolina and Texas. Donna Farmer, BSN, RN, CCM, has a clinical background in managing catastrophic illness and life care planning. She has been employed at Cigna since 2001 where she has worked as a case manager (CM), CM supervisor, and clinical program consultant. Stella M. John, BSN, RN, started at Cigna in 2005 as a catastrophic case manager and chronic condition kidney case manager. Currently, she holds the position of clinical coach with Cigna Workforce Development. Her 19 years' clinical experience includes surgical and medical ICU with a cardiac focus and intermediate care unit manager. Denise L. Sollars, BSN, RN, CCM, began her career with Cigna in August 2001. She is a certified nurse case manager and was part of the Case Management team for 12 years. She is currently a clinical consultant for the Mid-America Market. Before joining Cigna, Denise had 15 years' hospital clinical experience. John F. Rausch Jr., MD, FACP, FNKF, is board certified in Internal Medicine, has served as Board of Directors Chairman, National Kidney Foundation of Arizona, founding member and current Board of Directors member, Cardio Renal Society of America, and Medical Director at Cigna, Clinical Performance and Quality, Total Health and Network.
Purpose Of Study: Chronic kidney disease (CKD) is a costly and burdensome public health concern. The goal of this study was to evaluate the impact on outcomes and utilization of a pilot program to identify and engage beneficiaries with CKD at risk for progression from Stage 4 to Stage 5.
Primary Practice Settings: A quality improvement initiative was conducted to assess the impact of case management on costs and outcomes among 7,720 Cigna commercial medical beneficiaries with Stage 4 CKD enrolled in the United States between January 2012 and October 2012.
Romosozumab - Promising or Practice Changing?
N Engl J Med
October 2017
From Tufts University Medical School, Boston, and the Maine Medical Center Research Institute, Scarborough.
Reducing Hospital Readmissions: Addressing the Impact of Food Security and Nutrition.
J Law Med Ethics
March 2017
Mathew Swinburne, J.D., is a Senior Staff Attorney for the Network for Public Health Law. He received a J.D. from the University of Maryland Francis King Carey School of Law, Baltimore, MD and a B.S. from Tufts University, Medford, MA. Katie Garfield, J.D., M.Phil., is a Staff Attorney at the Center for Health Law and Policy Innovation of Harvard Law School. She received a J.D. from Harvard Law School, Cambridge, MA; MPhil from the University of Cambridge, Cambridge, UK; and B.A. from Yale University, New Haven, CT. Aliza R. Wasserman, M.P.H., was at the time of submission the Policy & Advocacy Manager for Wholesome Wave in Washington, DC. She received an M.S. and M.P.H. from Tufts University, Medford, MA and a B.S. from Cornell University, Ithaca, NY.
Food insecurity in the United States is a profound public health challenge that hospitals are uniquely situated to address. Through the enactment of the Hospital Readmission Reduction Program, the Affordable Care Act provides a strong economic incentive for hospitals to actively confront food insecurity within the communities they serve. While there is a spectrum of nutrition interventions that hospitals can look to when engaging in these efforts, healthy food prescriptions and medically tailored meals are two particularly innovative and promising approaches that could help hospitals reduce readmissions by addressing the nutritional needs of vulnerable patients.
View Article and Find Full Text PDFIt's the Prices, Advanced Capitalism, and the Need for Rate Setting - Stupid.
J Law Med Ethics
December 2016
David M. Frankford, J.D., is a Professor at Rutgers Law School; Professor at the Rutgers Institute for Health, Health Care Policy and Aging Research; and the faculty director at Camden of the Rutgers Center for State Health Policy. He has received his Bachelor of Arts degree in political science from Tufts University (Medford, MA) and also a Juris Doctor degree from the University of Chicago School of Law (Chicago, IL).
Competition cannot stem the rise of health care expenditures because it leaves agency diffuse and transferred in part to the institutions of advanced capitalism, which excel in generating demand for their services. The United States should turn to state rate setting to concentrate purchasing power.
View Article and Find Full Text PDF